About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2012 (2012), Article ID 450246, 8 pages
http://dx.doi.org/10.1155/2012/450246
Clinical Study

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

1Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK
2University of Manchester, Manchester M13 9PL, UK
3Department of Clinical Oncology, Raigmore Hospital, Inverness IV2 3UJ, UK

Received 29 February 2012; Accepted 13 April 2012

Academic Editor: Rami Ben-Yosef

Copyright © 2012 David Thomson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • S. Supiot, G. Créhange, I. Latorzeff, P. Pommier, A. Paumier, E. Rio, G. Delaroche, S. Guérif, C. Catton, J. Martin, and A. Lisbona, “Hypofractionnement à visée curative dans le cancer de la prostate,” Cancer/Radiothérapie, 2013. View at Publisher · View at Google Scholar
  • M. Guckenberger, I. Lawrenz, and M. Flentje, “Moderately hypofractionated radiotherapy for localized prostate cancer,” Strahlentherapie und Onkologie, 2013. View at Publisher · View at Google Scholar
  • A.C. Tree, V.S. Khoo, N.J. van As, and M. Partridge, “Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models?,” Clinical Oncology, 2014. View at Publisher · View at Google Scholar